A Transformational Year for Marlowe
Marlowe PLC’s latest results aren’t just another set of financial figures – they’re the punctuation mark at the end of a radical corporate rewrite. The testing, inspection and certification specialist has emerged from a year of strategic upheaval with a leaner structure, healthier finances, and a £366 million acquisition offer from facilities management giant Mitie Group on the table. Let’s unpack what this means for investors.
Financial Headlines: Slimmer & Stronger
Having shed its Governance, Risk & Compliance (GRC) software arm for £430 million and demerged its Occupational Health division (now Optima Health plc), Marlowe now operates purely within its core TIC markets: Fire Safety & Security and Water & Air Hygiene. The results reflect this streamlined focus:
- Revenue Growth (Continuing Operations): Up 4% to £304.5m, driven by organic growth.
- Adjusted EBITDA: Increased 4% to £32.8m, maintaining a 10.8% margin.
- Profit Transformation: Statutory operating profit swung to £5.0m from a £3.2m loss last year.
- Balance Sheet Revolution: Net cash position of £22.2m (excluding leases) versus net debt of £176.6m a year ago.
- Adjusted EPS Surge: Jumped 47% to 15.3p.
The Group’s statutory figures tell a more dramatic story, heavily influenced by the GRC sale:
- Group Profit Before Tax: £144.9m (FY24 loss: £10.9m), including the £141.4m profit on the GRC disposal.
- Group Basic EPS: 159.7p (FY24 loss per share: 10.6p).
The Mitie Offer: The Cherry on Top?
The standout news isn’t just the past year’s performance, but what’s proposed for the future. On 5th June 2025, Mitie Group announced a unanimously recommended cash and share offer:
- Offer Value: 466p per Marlowe share (based on Mitie’s 160p closing price on 4th June).
- Total Enterprise Value: Approximately £366 million.
- Premium: Roughly 39% above Marlowe’s three-month volume-weighted average price (335p).
Interim Chairman Lord Ashcroft framed the total shareholder value creation starkly:
“When taken together with the 210 pence per share distribution in September 2024 through the demerger of Optima Health, and the 155 pence special dividend paid in July 2024, the total value to Marlowe Shareholders equates to 831 pence per share… This represents a 164.5 percent premium to the Marlowe share price low of 314 pence on 7 December 2023.”
Unsurprisingly, the board is recommending shareholders accept. Given this pending transaction, Marlowe has paused its planned additional £15m share buyback.
Operational Performance: Fire & Water
Within the streamlined TIC division, performance was nuanced:
Fire Safety & Security (c.50% of TIC Revenue)
- Delivered mid-single-digit organic revenue growth and high single-digit EBITDA growth.
- Strength in mechanical fire protection (sprinklers, kitchen suppression).
- Improved engineer productivity (revenue per day per fee earner up to £800 in some areas).
- Strong compliance rates (98%) and improved first-time fix rates (78%).
Water & Air Hygiene (Just over 50% of TIC Revenue)
- Achieved low single-digit organic growth.
- Margins improved in H2 after operational challenges in H1.
- Now structured under unified brand ‘Marlowe Environmental Services’ (Water, Risk & Compliance, Environmental Engineering).
- Environmental Engineering was a strong performer (high single-digit growth).
- Post-year-end acquisition of SludgeTek (£6.2m) bolsters wastewater rental solutions.
- AMP8 regulatory cycle (£104bn water infrastructure investment 2025-2030) provides a significant tailwind.
Challenges & Looking Ahead
It hasn’t all been smooth sailing. The group flagged pressure on margins at the start of FY26 due to increased national insurance contributions and the rise in the national minimum wage. Integration costs from past acquisitions are now concluded, but ongoing operational efficiency remains key.
Trading since the year-end is described as “broadly in line” with expectations, underpinned by the resilient, compliance-driven nature of Marlowe’s services (approx. 75% recurring revenue). The highly fragmented TIC market still offers bolt-on acquisition potential – SludgeTek being a recent example.
Conclusion: Mission Accomplished?
Marlowe’s management embarked on a radical simplification: sell non-core assets, demerge another, return substantial capital to shareholders, and refocus entirely on the core TIC business. Financially, this has been executed impressively, transforming the balance sheet and improving underlying profitability in the continuing operations.
The Mitie offer appears as a validation of this strategy and offers shareholders an immediate premium and the chance to participate in a larger group. Whether shareholders take the cash and Mitie shares or not, the journey Marlowe’s board set out on in its strategic review looks fundamentally complete – and financially rewarding for those who held on through the transformation.
The final chapter? That likely rests with the shareholder vote on Mitie’s scheme of arrangement, expected in Q3 2025.
